Implications of the current tuberculosis treatment landscape for future regimen change
- 1 June 2011
- journal article
- research article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 15 (6), 746-753
- https://doi.org/10.5588/ijtld.10.0094
Abstract
BACKGROUND: The current tuberculosis (TB) treatment landscape has been studied extensively, but researchers rarely consider how it creates challenges or opportunities for future regimen change. METHODS: In 166 stakeholder interviews in the TB high-burden countries (HBCs), we investigated areas of first-line TB treatment and control that would affect, and be affected by, a future TB regimen change. Responses were compared with existing standardized data. RESULTS: Public sector regimens are converging towards a single standard, which facilitates comparison with a single control arm from clinical trials. However, final product design is challenging if the goal is fixed-dose combinations and patient kits, whose current widespread use addresses continuing weaknesses in drug management. Any product must address broad groups, as relatively low levels of drug susceptibility testing (DST) do not allow for individualized therapy. Finally, the protection of new drugs from the development of resistance will be challenging, as the implementation of directly observed therapy and public-private mix programs is incomplete, and substantial private sectors have been identified as early adopters of these drugs. CONCLUSIONS: Health systems for TB treatment and control must be improved not only to allow better implementation of current treatments but also to set the stage for implementation of new, improved TB regimens.Keywords
This publication has 6 references indexed in Scilit:
- Tuberculosis regimen change in high-burden countries2010
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences of the United States of America, 2009
- Emerging Drugs for Active TuberculosisSeminars in Respiratory and Critical Care Medicine, 2008
- Prospects for Advancing Tuberculosis Control Efforts through Novel TherapiesPLoS Medicine, 2006
- The process of changing national malaria treatment policy: lessons from country-level studiesHealth Policy and Planning, 2004
- Involving private health care providers in delivery of TB care: global strategyTuberculosis, 2003